CSIMarket
 


Escalon Medical Corp   (ESMC)
Other Ticker:  
 

Escalon Medical 's Leverage Ratio

ESMC's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to repayements of liabilities of -4.84% Escalon Medical improved Leverage Ratio in second quarter 2023 to 1.56, below the company's average Leverage Ratio.

Within Medical Equipment & Supplies industry in the second quarter 2023, 62 other companies have achieved lower Leverage Ratio than Escalon Medical in the II Quarter 2023. While Leverage Ratio total ranking has improved so far in the second quarter 2023 to 1061, from total ranking in the first quarter 2023 at 2220 .

Explain Leverage Ratio?
Who are ESMC Customers?
What are ESMC´s Total Liabilities?


ESMC Leverage Ratio (Dec 31 2023)
II. Quarter
(Sep 30 2023)
I. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
II. Quarter
(Sep 30 2022)
I. Quarter
Y / Y Equity Change 58.76 % 34.01 % 0.72 % -35.22 % -9.33 %
Y / Y Total Liabilities Change -23.89 % -15.95 % 12.88 % -5.26 % -12.34 %
Leverage Ratio MRQ 1.56 1.58 1.95 3.03 3.26
ESMC's Total Ranking # 1061 # 2220 # 2438 # 760 #
Seq. Equity Change -3.99 % 10.2 % 50.83 % -0.52 % -18.96 %
Seq. Total Liabilities Change -4.84 % -10.92 % -3.04 % -7.41 % 5.1 %



Leverage Ratio second quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 63
Healthcare Sector # 201
Overall Market # 1061


Leverage Ratio Statistics
High Average Low
52.78 3.32 0.69
(Sep 30 2012)   (Dec 31 2012)




Financial Statements
Escalon Medical 's Equity $ 2 Millions Visit ESMC's Balance sheet
Escalon Medical 's Total Liabilities $ 3 Millions Visit ESMC's Balance sheet
Source of ESMC's Sales Visit ESMC's Sales by Geography


Cumulative Escalon Medical 's Leverage Ratio

ESMC's Leverage Ratio for the trailling 12 Months

ESMC Leverage Ratio

(Dec 31 2023)
II. Quarter
(Sep 30 2023)
I. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
II. Quarter
(Sep 30 2022)
I. Quarter
Y / Y Equity TTM Growth 58.76 % 34.01 % 0.72 % -35.22 % -9.33 %
Y / Y Total Liabilities TTM Growth -23.89 % -15.95 % 12.88 % -5.26 % -12.34 %
Leverage Ratio TTM 1.92 2.29 2.6 2.54 2.31
Total Ranking TTM # 1508 # 2776 # # 3144 # 3621
Seq. Equity TTM Growth -3.99 % 10.2 % 50.83 % -0.52 % -18.96 %
Seq. Total Liabilities TTM Growth -4.84 % -10.92 % -3.04 % -7.41 % 5.1 %


On the trailing twelve months basis Due to repayements of liabilities of -4.84% Escalon Medical decreased Leverage Ratio in the 12 months ending in II Quarter 2023 to 1.92, below the company's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry ESMC recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has improved so far to 474, from total ranking in previous 12 month period at 8.

Explain Leverage Ratio?
Who are ESMC Customers?
What are ESMC´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 0
Healthcare Sector # 1
Within the Market # 1061


trailing twelve months Leverage Ratio Statistics
High Average Low
3.12 1.92 1.03
(Mar 31 2021)   (June 30. 2014)




Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within Medical Equipment & Supplies Industry Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Equity
Owens and Minor inc  4.23 $ 3,905.075  Millions$ 924.166  Millions
Petvivo Holdings Inc  3.06 $ 2.735  Millions$ 0.895  Millions
Bioventus Inc   2.88 $ 637.319  Millions$ 221.118  Millions
The Pennant Group Inc   2.74 $ 399.352  Millions$ 145.515  Millions
Insulet Corporation  2.53 $ 1,855.500  Millions$ 732.700  Millions
Baxter International Inc   2.35 $ 19,874.000  Millions$ 8,468.000  Millions
Neuronetics inc   2.29 $ 78.450  Millions$ 34.190  Millions
Nuwellis Inc   2.27 $ 6.780  Millions$ 2.990  Millions
Dexcom Inc   1.97 $ 4,076.300  Millions$ 2,068.600  Millions
Patterson Companies Inc   1.94 $ 1,887.968  Millions$ 972.165  Millions
Novocure Limited  1.93 $ 698.909  Millions$ 362.496  Millions
Zynex inc   1.88 $ 86.850  Millions$ 46.129  Millions
Tandem Diabetes Care Inc   1.84 $ 577.972  Millions$ 313.632  Millions
Artivion Inc   1.81 $ 510.617  Millions$ 281.780  Millions
Intelligent Bio Solutions Inc   1.76 $ 5.547  Millions$ 3.154  Millions
Conmed Corporation  1.68 $ 1,404.897  Millions$ 834.222  Millions
Stereotaxis Inc   1.56 $ 25.566  Millions$ 16.343  Millions
Escalon Medical Corp   1.56 $ 2.869  Millions$ 1.837  Millions
Henry Schein Inc  1.36 $ 5,840.000  Millions$ 4,289.000  Millions
Shockwave Medical Inc   1.34 $ 897.886  Millions$ 668.677  Millions
Beyond Air Inc   1.32 $ 31.097  Millions$ 23.471  Millions
Cytosorbents Corporation  1.29 $ 29.985  Millions$ 23.275  Millions
Msa Safety Incorporated  1.24 $ 1,203.348  Millions$ 966.802  Millions
Masimo Corp  1.23 $ 1,676.700  Millions$ 1,364.800  Millions
Cadre Holdings Inc   1.19 $ 234.017  Millions$ 197.162  Millions
Haemonetics Corporation  1.19 $ 1,118.604  Millions$ 943.319  Millions
Integra Lifesciences Holdings Corp  1.18 $ 1,878.914  Millions$ 1,587.884  Millions
Quoin Pharmaceuticals Ltd   1.15 $ 6.505  Millions$ 5.664  Millions
Electrocore Inc   1.08 $ 8.034  Millions$ 7.442  Millions
Adm Tronics Unlimited Inc   1.06 $ 1.168  Millions$ 1.103  Millions

Date modified: 2024-02-17T00:01:06+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com